http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013245089-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd2ca29dcc6b1f6b13e1792f681f258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_096b3cddcf2527d587252b9a975f2ef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e43b45e7e804385eaaa9512f18257bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92facb4e5f87e281f4e9142ce7270881
publicationDate 2013-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2013245089-A1
titleOfInvention Method for administration
abstract There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017362040-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017362040-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017227544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3459933-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018092020-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019180576-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11192898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015198266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419870-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3160463-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019298719-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020128892-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10966978-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3541387-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018178925-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4249513-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020128898-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2762573-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020128894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109982702-A
priorityDate 2012-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010152190-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249058389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226765260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53358942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422364244

Total number of triples: 43.